Common prognostic indicators of glioblastoma include Karnofsky performance status (KPS), age, extent of tumor resection, radiotherapy, chemotherapy, tumor size, tumor location, and molecular profiling for biomarkers such as IDH1, EGFR, PTEN, and MGMT. Here, MGMT is linked to glioblastoma.